Renovaro (RENB) Stock Price, News & Analysis

Company Overview

Renovaro (NASDAQ:RENB) is a leading provider of residential and commercial renovation services in North America. Since its founding in 2010, the company has established a reputation for delivering comprehensive building restoration, remodeling, and energy efficiency solutions. Renovaro’s business model integrates end-to-end project management with a focus on sustainable materials and technology-driven workflows, allowing clients to optimize both cost and environmental impact.

The company’s core offerings encompass design-build services, interior and exterior renovations, and specialized upgrades such as high-performance insulation, smart home integration, and renewable energy installations. Renovaro leverages proprietary digital platforms to streamline project estimation, scheduling, and real-time progress tracking, enhancing transparency and client engagement throughout the renovation lifecycle. In addition, the company maintains a network of certified subcontractors and materials suppliers to ensure consistent quality and compliance with industry standards.

Renovaro primarily serves markets across the United States and Canada, targeting urban centers with high demand for retrofit and sustainability-focused building improvements. Over the past decade, Renovaro has expanded its footprint through the acquisition of regional remodeling firms and strategic partnerships with energy utilities and real estate developers. This pan-regional approach has enabled the company to adapt its service offerings to diverse regulatory environments and local building codes.

Under the leadership of CEO Jonathan Patel and CFO Michelle Chen, Renovaro continues to explore growth avenues in emerging markets and smart city initiatives. The management team emphasizes a disciplined, customer-centric growth strategy, with ongoing investments in technological innovation, workforce development, and strategic alliances. Renovaro’s board includes industry veterans with backgrounds in construction, finance, and sustainability, positioning the company for continued evolution in the dynamic renovation services sector.

Key Stats

• Today's Range: $0.29 to $0.31
• 50-Day Range: $0.27 to $0.38
• 52-Week Range: $0.27 to $2.10
• Volume: 1.17 million shs
• Average Volume: 1.57 million shs
• Market Capitalization: $52.62 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Renovaro Stock Analysis - MarketRank™

Renovaro scored higher than 20% of companies evaluated by MarketBeat, and ranked 847th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Renovaro.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Renovaro is -0.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Renovaro is -0.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Renovaro has a P/B Ratio of 0.34. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.97% of the float of Renovaro has been sold short.

Short Interest Ratio / Days to Cover

Renovaro has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Renovaro has recently increased by 6.61%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Renovaro does not currently pay a dividend.

Dividend Growth

Renovaro does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

5.97% of the float of Renovaro has been sold short.

Short Interest Ratio / Days to Cover

Renovaro has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Renovaro has recently increased by 6.61%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: 0.53

News Sentiment

Renovaro has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Renovaro this week, compared to 2 articles on an average week.

MarketBeat Follows

1 people have added Renovaro to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Renovaro insiders have not sold or bought any company stock.

Percentage Held by Insiders

21.72% of the stock of Renovaro is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

71.41% of the stock of Renovaro is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

RENB Stock Analysis - Frequently Asked Questions

How have RENB shares performed this year?

Renovaro's stock was trading at $0.8355 at the start of the year. Since then, RENB shares have decreased by 63.4% and is now trading at $0.3057.

How were Renovaro's earnings last quarter?

Renovaro Inc. (NASDAQ:RENB) issued its quarterly earnings data on Wednesday, February, 19th. The company reported ($0.02) EPS for the quarter.

How do I buy shares of Renovaro?

Shares of RENB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Renovaro own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Renovaro investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Adobe (ADBE), Arista Networks (ANET), e.l.f. Beauty (ELF) and ServiceNow (NOW).

Company Calendar

• Last Earnings: 2/19/2025
• Today: 7/08/2025
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:RENB
• CIK: 1527728
• Web: www.enochianbio.com
• Phone: 305-918-1980
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.77)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$88.43 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -60.38%
• Return on Assets: -47.04%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.13
• Quick Ratio: 0.13

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.89 per share
• Price / Book: 0.34

Miscellaneous

• Outstanding Shares: 172,120,000
• Free Float: 134,735,000
• Market Cap: $52.62 million
• Optionable: Optionable
• Beta: 0.51